This model involves three different mechanisms: (1) REDD1 upregulation, (2) AMPK activation resulting in mTOR inhibition through the activation of the TSC1/TSC2 tumour suppressor complex [33, 34], and (3) mTOR accumulation in the nucleus through the action of the PML tumour suppressor [35]. The gene discussed is TSC2; the disease is neoplasm.